What's new — Anorexia nervosa¶
Generated 2026-11-01 from the publication dates of every paper cited in this condition's pages.
This page answers a different question from the curation log. The log says when we last edited a page; this says how recent the evidence on those pages is — so you can tell settled ground from a field that is actively moving, and jump straight to what has emerged lately.
How much of this condition's evidence is recent¶
| Published within | Cited papers |
|---|---|
| last week | 0 |
| last month | 2 |
| last 2 months | 8 |
| last 3 months | 9 |
| last 6 months | 17 |
| last year | 30 |
| older than a year | 267 |
Counts are cumulative: a paper from last week also counts inside "last month". Dates are PubMed publication or e-publication dates, so a paper may have appeared online before its journal issue.
Newest evidence first¶
The most recent cited papers, with the pages that use them.
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-08 | Increased frequency of rare damaging variants in PLIN4 in patients with anorexia nervosa — Front Psychiatry ([PMID 42923416](https://pubmed.ncbi.nlm.nih.gov/42923416/){target="_blank" rel="noopener"}) | genetics |
| 2026-10-02 | Patient and caregiver characteristics and outcomes following compulsory admission for anorexia nervosa treatment — BJPsych Open ([PMID 42929079](https://pubmed.ncbi.nlm.nih.gov/42929079/){target="_blank" rel="noopener"}) | severe-enduring-illness-and-compulsory-treatment |
| 2026-10-01 | Intensive Nutritional Interventions for Anorexia Nervosa: A Commentary on Ino et al. (2026) — Int J Eat Disord ([PMID 42870371](https://pubmed.ncbi.nlm.nih.gov/42870371/){target="_blank" rel="noopener"}) | severe-enduring-illness-and-compulsory-treatment |
| 2026-10-01 | Consensus-based clinical and research recommendations for use of glucagon-like peptide-1 receptor agonists in the context of eating disorders: a modified Delphi study — World Psychiatry ([PMID 42742590](https://pubmed.ncbi.nlm.nih.gov/42742590/){target="_blank" rel="noopener"}) | guidelines |
| 2026-09-03 | Transcranial Direct Current Stimulation in Anorexia Nervosa: A Randomized Sham-Controlled Trial — J Clin Med ([PMID 42739834](https://pubmed.ncbi.nlm.nih.gov/42739834/){target="_blank" rel="noopener"}) | neuromodulation-and-experimental-therapy |
| 2026-09-02 | Characteristics of Monozygotic Twins Discordant for Anorexia Nervosa: Comprehensive Risk Evaluation for Anorexia Nervosa in Twins (CREAT) Study — Eur Eat Disord Rev ([PMID 42683660](https://pubmed.ncbi.nlm.nih.gov/42683660/){target="_blank" rel="noopener"}) | genetics |
| 2026-09-01 | Brazilian Psychiatric Association guidelines for the treatment of eating disorders — Braz J Psychiatry ([PMID 42758807](https://pubmed.ncbi.nlm.nih.gov/42758807/){target="_blank" rel="noopener"}) | guidelines |
| 2026-09-01 | Integrative Genomic and Functional Investigation of the Multi-Layered Genetic Architecture Between Anorexia Nervosa and Bone Loss — Int J Eat Disord ([PMID 42753153](https://pubmed.ncbi.nlm.nih.gov/42753153/){target="_blank" rel="noopener"}) | genetics |
| 2026-08-05 | An Invited Updated Systematic Review and Meta-Analysis Comparing Atypical Anorexia Nervosa and Anorexia Nervosa — Int J Eat Disord ([PMID 42557659](https://pubmed.ncbi.nlm.nih.gov/42557659/){target="_blank" rel="noopener"}) | diagnosis-and-classification, epidemiology-and-incidence, guidelines, medical-complications, mortality-and-long-term-outcome, overview, patient-experience-and-advocacy, red-flags-and-safety-concerns |
| 2026-08-01 | Genomic meta-analyses of binge-eating behavior and anorexia nervosa yield insights into the unique and shared biology of eating disorder phenotypes — Nat Ment Health ([PMID 42718672](https://pubmed.ncbi.nlm.nih.gov/42718672/){target="_blank" rel="noopener"}) | genetics |
| 2026-07-06 | Stakeholder views on the proposed criteria for 'terminal anorexia': a mixed-methods study — Eat Disord ([PMID 42410953](https://pubmed.ncbi.nlm.nih.gov/42410953/){target="_blank" rel="noopener"}) | patient-experience-and-advocacy, severe-enduring-illness-and-compulsory-treatment |
| 2026-07-01 | Theta burst stimulation of extrastriate body area for body perception in anorexia nervosa: a randomized controlled trial — Transl Psychiatry ([PMID 42386712](https://pubmed.ncbi.nlm.nih.gov/42386712/){target="_blank" rel="noopener"}) | neuromodulation-and-experimental-therapy |
| 2026-07-01 | Excess Mortality Among Patients With Anorexia Nervosa Treated Involuntarily — Int J Eat Disord ([PMID 42383339](https://pubmed.ncbi.nlm.nih.gov/42383339/){target="_blank" rel="noopener"}) | clinical-trials-landscape, guidelines, mortality-and-long-term-outcome, red-flags-and-safety-concerns, severe-enduring-illness-and-compulsory-treatment |
| 2026-06-01 | What are the arguments for and against recognizing 'terminal' anorexia nervosa? A narrative review — Int Rev Psychiatry ([PMID 42312722](https://pubmed.ncbi.nlm.nih.gov/42312722/){target="_blank" rel="noopener"}) | severe-enduring-illness-and-compulsory-treatment |
| 2026-06-01 | A randomized controlled trial of brief interoceptive exposure and family-based treatment for adolescents with low-weight eating disorders — J Child Psychol Psychiatry ([PMID 42310840](https://pubmed.ncbi.nlm.nih.gov/42310840/){target="_blank" rel="noopener"}) | clinical-trials-landscape, treatment-in-adolescents |
| 2026-06-01 | Epidemiology of Intensive Nutritional Interventions and Restraints in Hospitalizations for Anorexia Nervosa: Annual National Trends of the United States — Int J Eat Disord ([PMID 42286444](https://pubmed.ncbi.nlm.nih.gov/42286444/){target="_blank" rel="noopener"}) | severe-enduring-illness-and-compulsory-treatment |
| 2026-06-01 | Efficacy and safety of repetitive transcranial magnetic stimulation in anorexia and bulimia nervosa: a systematic review and meta-analysis — Ann Gen Psychiatry ([PMID 42226264](https://pubmed.ncbi.nlm.nih.gov/42226264/){target="_blank" rel="noopener"}) | neuromodulation-and-experimental-therapy |
| 2026-05-02 | Investigating Relationships Between Genetic Risk, Childhood Maltreatment, and Eating Disorders in Women — Biol Psychiatry Glob Open Sci ([PMID 42471970](https://pubmed.ncbi.nlm.nih.gov/42471970/){target="_blank" rel="noopener"}) | genetics |
| 2026-05-01 | Olanzapine for young people with anorexia nervosa: a synopsis of the main results from the OPEN open-label feasibility study — Health Technol Assess ([PMID 42116676](https://pubmed.ncbi.nlm.nih.gov/42116676/){target="_blank" rel="noopener"}) | clinical-trials-landscape, pharmacotherapy |
| 2026-04-03 | Integrative GWAS identifies novel loci and genetic links between psychiatric and metabolic factors in anorexia nervosa — Mol Psychiatry ([PMID 41927769](https://pubmed.ncbi.nlm.nih.gov/41927769/){target="_blank" rel="noopener"}) | genetics |
| 2026-04-02 | Protocol for a pilot feasibility randomised controlled trial of fecal microbiota transplantation for adolescent anorexia nervosa — BMJ Open ([PMID 42009386](https://pubmed.ncbi.nlm.nih.gov/42009386/){target="_blank" rel="noopener"}) | genetics |
| 2026-02-01 | Medication use in severe anorexia nervosa: a Danish register-based study — BMJ Ment Health ([PMID 41688100](https://pubmed.ncbi.nlm.nih.gov/41688100/){target="_blank" rel="noopener"}) | pharmacotherapy |
| 2026-02-01 | All-cause and cause-specific mortality risk in individuals with eating disorders: systematic review and meta-analysis of relative risk and aggravating or attenuating factors — World Psychiatry ([PMID 41536100](https://pubmed.ncbi.nlm.nih.gov/41536100/){target="_blank" rel="noopener"}) | mortality-and-long-term-outcome, overview, red-flags-and-safety-concerns |
| 2026-01-02 | Effects of teriparatide on hip structure and bone microarchitecture in women with anorexia nervosa: a placebo-controlled randomized trial — Osteoporos Int ([PMID 41591404](https://pubmed.ncbi.nlm.nih.gov/41591404/){target="_blank" rel="noopener"}) | medical-complications |
| 2026-01-02 | Clinicians' Experiences With Providing Compulsory Nasogastric Tube Feeding: A Commentary on Offringa et al. (2025) — Int J Eat Disord ([PMID 41481023](https://pubmed.ncbi.nlm.nih.gov/41481023/){target="_blank" rel="noopener"}) | patient-experience-and-advocacy |
| 2026-01-01 | Impact of a single fecal microbiome transplantation in adult women with anorexia nervosa: an open-label feasibility pilot trial — Nat Commun ([PMID 41535289](https://pubmed.ncbi.nlm.nih.gov/41535289/){target="_blank" rel="noopener"}) | genetics |
| 2025-11-03 | Clinicians' Experiences of Providing Compulsory Care for Youth With Anorexia Nervosa: A Qualitative Study — Int J Eat Disord ([PMID 41185403](https://pubmed.ncbi.nlm.nih.gov/41185403/){target="_blank" rel="noopener"}) | patient-experience-and-advocacy |
| 2025-11-02 | Systematic Review and Meta-Analysis of Mortality in Patients With Anorexia Nervosa — Int J Eat Disord ([PMID 41277145](https://pubmed.ncbi.nlm.nih.gov/41277145/){target="_blank" rel="noopener"}) | mortality-and-long-term-outcome, overview, red-flags-and-safety-concerns |
| 2025-11-01 | Anorexia nervosa symptoms are induced after specific gut microbiota dysbiosis transfer in germ-free mice — Gut Microbes ([PMID 41239983](https://pubmed.ncbi.nlm.nih.gov/41239983/){target="_blank" rel="noopener"}) | genetics |
| 2025-11-01 | Intensive community and home-based treatments for eating disorders: a scoping review — J Eat Disord ([PMID 41214774](https://pubmed.ncbi.nlm.nih.gov/41214774/){target="_blank" rel="noopener"}) | service-models-and-setting |
Trials — what has moved¶
50 registered trials are cited by this condition's pages. Registry records were re-checked live when this page was generated, so status, enrolment and results-posting below reflect ClinicalTrials.gov as of that date.
| Registry activity | Trials |
|---|---|
| trial records updated in the last week | 1 |
| trial records updated in the last month | 4 |
| trial records updated in the last 2 months | 7 |
| trial records updated in the last 3 months | 12 |
| trial records updated in the last 6 months | 17 |
| trial records updated in the last year | 23 |
Recently updated registrations¶
Posted efficacy and safety results¶
Trials whose sponsors have posted results to the registry. Adverse-event figures are participant counts summed across all arms as reported — read them against enrolment, and follow the registry link for the arm-by-arm breakdown that determines whether a signal is real.
| Results posted | Trial | Phase | N | Primary outcome | Serious AE | Other AE | Deaths |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | Individualized Study of Refeeding to Optimize iNpatient Gains | NA | 77 | Time to Achieve Medical Stability in Hospital | 10 | 11 | 0 |
| 2021-06-24 | Study of Refeeding to Optimize iNpatient Gains | NA | 120 | Number of Participants With Clinical Remission at Different Time Point | 24 | 35 | 0 |
| 2016-07-11 | Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Wo | PHASE4 | 93 | Proportion of Patients Remaining in Study at 1 Year | 1 | 0 | 0 |
| 2016-02-02 | A Double-blind, Placebo Controlled Trial of Risperidone for the Treatm | PHASE4 | 41 | Change in Eating Disorder Inventory-2 Drive for Thinness Subscale (DT) | 0 | 33 | 0 |
31 of these trials are still recruiting or active — see the condition's clinical trials page for the full landscape.
Which pages rest on the newest evidence¶
🔥 marks a page citing three or more papers from the last year — the pages worth re-reading if you have been away.
| Page | Newest citation | In last year | Total citations |
|---|---|---|---|
| genetics | 2026-10-08 | 9 | 34 |
| severe-enduring-illness-and-compulsory-treatment | 2026-10-02 | 6 | 29 |
| guidelines | 2026-10-01 | 4 | 24 |
| neuromodulation-and-experimental-therapy | 2026-09-03 | 3 | 26 |
| diagnosis-and-classification | 2026-08-05 | 1 | 19 |
| epidemiology-and-incidence | 2026-08-05 | 1 | 20 |
| medical-complications | 2026-08-05 | 2 | 25 |
| mortality-and-long-term-outcome | 2026-08-05 | 4 | 22 |
| overview | 2026-08-05 | 3 | 28 |
| patient-experience-and-advocacy | 2026-08-05 | 4 | 25 |
| red-flags-and-safety-concerns | 2026-08-05 | 4 | 20 |
| clinical-trials-landscape | 2026-07-01 | 3 | 23 |
| treatment-in-adolescents | 2026-06-01 | 1 | 21 |
| pharmacotherapy | 2026-05-01 | 2 | 21 |
| service-models-and-setting | 2025-11-01 | 1 | 21 |
| refeeding-and-nutritional-rehabilitation | 2025-02-01 | 0 | 19 |
| treatment-in-adults | 2025-02-01 | 0 | 18 |
| neurobiology-and-cognition | 2024-11-01 | 0 | 31 |
Recency is not quality: an old paper may be the definitive one, and a new paper may not replicate. Use this to find movement, not to rank evidence. See open questions for what remains unresolved, and the curation log for when these pages were last revised.